FDA Approves Atopic Dermatitis Label Expansion for Arcutis’ Zoryve Topical Cr...
Pictured: Woman scratching her arm/iStock, Doucefleur The FDA on Tuesday approved the label expansion for Arcutis Biotherapeutics’ topical cream Zoryve (roflumilast), opening up its use to treat mild to moderate atopic dermatitis in adults and children …